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mef2 genes encode alternatively spliced transcription factor isoforms that function in muscle differentiation in both
Drosophila and vertebrates. Drosophila mef2 (Dmef2) has been shown to be required for the differentiation of a variety of
istinct muscle types. However, many possible aspects of its function in muscle remain unexplored. There has also been no
nalysis in vivo of the activity of different MEF2 isoforms in any species. Our investigation centred on the role of different
evels of DMEF2 in the Drosophila embryo in regulating diverse events of muscle differentiation and on the functional
ignificance of Dmef2 alternative splicing. We used the GAL4/UAS system to both misexpress and overexpress individual
MEF2 isoforms and to rescue the different aspects of the Dmef2 mutant phenotype. Ectopic ectodermal expression of
MEF2 activated muscle gene expression and inhibited epidermal differentiation. Overexpression of DMEF2 in the
esoderm disrupted differentiation of the somatic and visceral muscle and the heart. The use of different DMEF2 levels in
he rescue experiments revealed an activity range compatible with differentiation of the different muscle types: the
onsequence of too little or too much DMEF2 activity was disrupted differentiation. These rescue experiments also revealed
hat distinct DMEF2 thresholds are required for different properties within a cell and also for different cells within a muscle
ype and for different muscle types. Finally, each isoform functioned equivalently in these experiments, including in the
tringent test of rescue of the Dmef2 mutant phenotype. © 1999 Academic Press
Key Words: alternative splicing; Drosophila MEF2; muscle differentiation; protein isoforms; transcription factor
hresholds.
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The mesoderm in Drosophila is formed by the invagina-
tion during gastrulation of the most ventral cells of the
blastoderm embryo (reviewed in Bate, 1993). A range of cell
types subsequently differentiate from it, including the vari-
ous types of muscle: somatic (or body wall), visceral (or gut),
heart, pharyngeal, and alary. While the basic mechanisms
underlying the early events of mesoderm formation and its
subdivision into different cell populations are quite well-
understood, less is known about the later events during the
segregation and differentiation of the major muscle types. It
is, however, already apparent that there are many similari-
ties between Drosophila and vertebrates in muscle devel-
pment, both in the signals that regulate muscle commit-
1 These two authors contributed equally to this work.
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130ent, e.g., members of the Wnt, BMP, and Hedgehog
amilies, and in the transcriptional regulators of muscle
ene expression, e.g., members of the Tinman, MyoD, and
EF2 families (for reviews see Yun and Wold, 1996; Fish-
an and Olson, 1997; Baylies et al., 1998).
mef2 genes have pivotal roles in muscle differentiation.
hey encode MADS-box transcription factors (reviewed in
hore and Sharrocks, 1995) that bind an A-T-rich motif
ound in many muscle gene promoters and enhancers
Gossett et al., 1989; Pollock and Treisman, 1991). Four
ef2 genes (mef2 A–D) have been identified in vertebrates.
hey synergise with the MyoD family in initiating myo-
enesis (Kaushal et al., 1994; Molkentin et al., 1995), and in
ice mef2C is required for aspects of cardiac and smooth
uscle development (Q. Lin et al., 1997, 1998). Drosophila
as a single mef2 gene, Dmef2 (Lilly et al., 1994; Nguyen et
l., 1994; Taylor et al., 1995). During development Dmef2 is
xpressed in the mesodermal primordium and then in the
0012-1606/99 $30.00
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131MEF2 Thresholds for Drosophila Muscle Differentiationdifferent muscle lineages throughout embryogenesis.
Dmef2 has an essential role in muscle differentiation. In
Dmef2 mutant embryos the heart and the somatic, visceral,
pharyngeal, and alary muscles all fail to complete differen-
tiation (Bour et al., 1995; Lilly et al., 1995; Ranganayakulu
t al., 1995; this paper). Nevertheless, some features of
ifferentiation do occur in these embryos. For example, the
tructure of the heart develops, there are a significant
umber of myosin-expressing visceral muscle cells sur-
ounding the foregut and hindgut (Bour et al., 1995), and
ithin the somatic mesoderm there are a limited number of
tretched, multinucleated cells which can attract appropri-
te innervation (Prokop et al., 1996). So, whilst many
events of the differentiation of the different muscle types
are Dmef2-dependent, there are others that are Dmef2-
independent.
In common with many transcription factors, both the
Drosophila and the vertebrate mef2 genes give rise to
multiple protein isoforms through alternative splicing of
their primary transcripts. The Dmef2 gene produces at least
four distinct isoforms through alternative splicing outside
its DNA-binding/dimerisation domain (Taylor et al., 1995;
this paper). An important question is whether different
isoforms have different functions. It has been shown that
different isoforms of mammalian MEF2A, 2C, and 2D have
similar DNA-binding properties in vitro and induce com-
parable transcriptional activation of reporter genes after
transfection into cultured HeLa cells and 10T1/2 fibroblasts
(Yu et al., 1992; Breitbart et al., 1993; McDermott et al.,
1993; Martin et al., 1994). There may, however, be func-
tional differences between the isoforms that are not evident
in these types of assay and that are only revealed in vivo.
There has been no such analysis for any MEF2 protein.
More generally, although alternative splicing of transcrip-
tion factors to produce different isoforms is widespread in
development, there has been rather little assessment in
vivo of possible different functions of such isoforms during
embryogenesis (reviewed in Lopez, 1995).
The role of different levels of protein activity is an
important aspect to protein function in animal develop-
ment. This has generally been investigated in the context of
morphogens and patterning genes that govern the establish-
ment of the body plan and determine cell fate (see, for
example, Gurdon et al., 1998). One can ask whether levels
are also important later in the process of cell differentiation
and, in particular, muscle differentiation. A recent study
has begun to address this for the myogenic bHLH family
member, myogenin (Vivian et al., 1999). However, there has
been no such investigation into the MEF2 proteins which
operate alongside this family, although there are observa-
tions that are consistent with a role for different levels of
DMEF2. First, Dmef2 expression in the embryo is not
uniform, rather it is complex and dynamic and some cells
express higher levels than others (Lilly et al., 1994; 1995;
Nguyen et al., 1994, Taylor et al., 1995; Bour et al., 1995).
Second, analysis of the Dmef2 gene regulatory sequences
has revealed distinct enhancer elements that are activated
Copyright © 1999 by Academic Press. All rightat different times in a muscle type, that are active in subsets
of the cells in a muscle type, and that are active in different
muscle types (Schulz et al., 1996; Gajewski et al., 1997,
1998; Cripps et al., 1998; Nguyen and Xu, 1998). This is the
arrangement one would expect if levels of DMEF2 were
tightly controlled both within a cell and in different cells
and muscle types. Thus, there is evidence that levels of
DMEF2 are specifically regulated during embryonic devel-
opment. Moreover, there are two pieces of work from which
one can infer that these levels of DMEF2 may be important
in muscle differentiation. Both are for the specific case of
somatic muscle differentiation. First, overexpression of
DMEF2 in the mesoderm disrupted somatic muscle differ-
entiation (M. Lin et al., 1997). Second, analysis of three
hypomorphic Dmef2 alleles has shown that in the weakest
some somatic muscles were missing, in the intermediate
more muscles were missing, and in the strongest there was
an almost complete lack of normal muscle formation (Ran-
ganayakulu et al., 1995). On the basis of this somatic
muscle phenotype, these alleles can be placed in an allelic
series, which in turn suggests that some somatic muscles
require lower levels of Dmef2 function for their differentia-
tion than others. However, there is the significant caveat
that the study may have revealed allele-specific effects (the
mutations all result in the production of different DMEF2
proteins) and cannot be interpreted simply in terms of the
level of DMEF2 (Olson et al., 1995).
In the work reported here we address two principle issues.
They are of specific significance to the function of MEF2
proteins in muscle development, but are also of more
general importance to the function of transcription factors
in cell differentiation. The first aim was to determine the
effect of different levels of DMEF2 activity on the diverse
events of differentiation within each of the five different
muscle-types. We tested this directly and in detail. We
added back different levels of DMEF2 to Dmef2 mutant
embryos and assessed numerous parameters in the different
muscle lineages. The second aim was to assess for the first
time the function of MEF2 isoforms in vivo during embryo-
genesis, including using the stringent test of rescue of the
Dmef2 mutant phenotype. We report a new facet to the
function of DMEF2. We found that different properties
within a cell require distinct threshold levels of DMEF2, as
do different cells within a muscle type and different muscle
types. Furthermore, there is a DMEF2 activity range that is
compatible with the proper differentiation of different
muscle types. Finally, we found that each DMEF2 isoform
functions similarly, both when ectopically expressed in the
ectoderm and, strikingly, in the rescue of each aspect of the
Dmef2 mutant phenotype assayed.
MATERIALS AND METHODS
Genomic DNA CharacterisationDmef2 genomic DNA was isolated by screening a lEMBL3
genomic library at high stringency with a cDNA probe for the
s of reproduction in any form reserved.
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132 Gunthorpe, Beatty, and TaylorDmef2 coding sequence. l DNA was purified and three overlapping
clones were analysed by Southern blot. The genomic structure of
one clone encompassing the entire Dmef2 coding sequence was
determined after DNA sequencing at the automated facility in the
Department of Genetics, Cambridge University, using primers
derived from various positions along the cDNA sequence.
Generation of UAS-Dmef2 Stocks
An approximately 3.0-kb EcoRI–NotI fragment from each Dmef2
cDNA containing the entire coding sequence (Taylor et al., 1995)
was subcloned between the EcoRI and NotI sites of the pUAST
vector (Brand and Perrimon, 1993). Transgenic lines containing the
UAS-Dmef2 constructs were generated by injection of yw embryos
according to published procedures (Rubin and Spradling, 1982;
Spradling and Rubin, 1982), and stocks homozygous for the UAS
construct on the third chromosome were made.
Drosophila Strains and Crosses
The following strains of flies were used: Oregon R, Dmef222.21
(Bour et al., 1995), Dmef2113, Dmef2424 and Dmef265 (Rangana-
yakulu et al., 1995), wgcx4 (Baker, 1987), da-GAL4 (Wodarz et al.,
1995), twist-GAL4; twist-GAL4 (Baylies and Bate, 1996), 24BGAL4
(Brand and Perrimon, 1993), UAS-Dmef2 (Bour et al., 1995), and the
AS-Dmef2 constructs described above. For ectopic expression in
he ectoderm, UAS-Dmef2 homozygous stocks were crossed to a
tock homozygous for da-GAL4. For overexpression within the
esoderm, the same UAS-Dmef2 homozygous stocks were crossed
o a stock homozygous for two copies of twist-GAL4. For rescue of
he Dmef222.21 mutant phenotype, the UAS-Dmef2 and 24BGAL4
ines were recombined into the Dmef222.21 mutant background.
Males carrying the UAS-Dmef2 construct in the Dmef222.21 mutant
background (Dmef222.21/CyO wgen11 lacZ;UAS-Dmef2/UAS-Dmef2)
for balancer chromosome see Kassis et al., 1992) were then crossed
o virgin females carrying 24BGAL4 in the Dmef222.21 mutant
ackground (Dmef222.21/CyO wgen11 lacZ;24B/24B). Twenty-five
percent of the progeny were homozygous for the Dmef222.21 muta-
tion and carried one copy of 24BGAL4 and a UAS-Dmef2 construct,
and were identified by simultaneous immunostaining for muscle
myosin and b-galactosidase (to detect the balancer chromosome).
rosses were at 29°C unless otherwise stated.
Cuticle Preparations and Histochemistry
Cuticles were prepared according to the method of Wieschaus
and Nu¨sslein-Volhard (1986), except that embryos were not fixed
before mounting. In situ hybridisations in whole-mount embryos
with digoxygenin-labelled probes were performed according to the
method of Tautz and Pfeifle (1989) as modified by M. Ruiz-Gomez
(Ruiz-Gomez and Ghysen, 1993). Embryos were mounted in 70%
glycerol and photographed on a Zeiss Axioplan microscope. Immu-
nological staining of whole-mount embryos, using the Vectastain
ABC Elite Kit (Vectalabs), was as described in Ruiz-Gomez and
Ghysen (1993). Stained embryos were embedded in Araldite and
photographed as above. Antibodies were used at the following
dilutions: anti-muscle myosin (Kiehart and Feghali, 1986), 1:500;
anti-engrailed (Patel et al., 1989), 1:600; anti-Zfh-1 (Lai et al., 1991),
1:100; anti-b-galactosidase (Cappel), 1:10000; biotinylated anti-
rabbit and anti-mouse secondary antibodies (Vector Laboratories),
1:400.
D
D
Copyright © 1999 by Academic Press. All rightWestern Blots
Protein samples were prepared from late stage 12 to stage 14
dechorionated embryos. Embryos were homogenised in lysis buffer
(10 mM Hepes, pH 7.4, 5 mM EGTA, 5 mM EDTA, 0.44%
benzamide, 5% SDS, protease inhibitors (0.5 mM PMSF, and
antipain, TLCK, pepstatin A, leupeptin, aprotinin at 1 mg/mL)) and
then boiled for 4 min before addition of 23 loading buffer (0.1 M
Tris–HCl, pH 6.8, 20% glycerol, 10% b-mercaptoethanol, 4% SDS,
.2% bromophenol blue) and then boiled for a further 4 min. The
rotein samples were separated by SDS–PAGE and blotted onto
mmobilon P PVDF paper (Millipore). Antibodies were used on the
lot at the following concentrations: anti-DMEF2 (a gift from B.
aterson), 1:2500; anti-b-tubulin (E7 Ab; Developmental Studies
Hybridoma Bank, Iowa), 1:1000; secondary peroxidase-tagged anti-
bodies (Jackson), 1:10000. Protein bands were revealed with the
Super Signal enhanced chemiluminescence kit (Pierce). To identify
the DMEF2 band, Dmef222.21 embryos, which produce no DMEF2
protein, were collected after recombining the Dmef222.21 allele into
wingless mutant (wgcx4) background. Homozygous wg embryos,
which are also homozygous for Dmef222.21, were recognised visually
and collected under a dissecting microscope and their protein
extract was run alongside that from wild-type embryos. For detec-
tion of the DMEF2 protein expressed in the Dmef222.21 mutant
henotype rescue experiments, the UAS-Dmef2 and 24BGAL4
ines were recombined into a Dmef222.21, wgcx4 double-mutant
background. Crosses were then performed as for the phenotypic
analysis of the rescue. The 25% of the progeny homozygous for
Dmef222.21, wgcx4 were recognised visually and collected. Levels of
DMEF2 protein expression were estimated using the public domain
NIH Image program (available at http://rsb.info.gov/nih-image/)
and normalising against the b-tubulin loading control.
RESULTS
Genomic Structure of Dmef2 Coding Sequence
We have previously described Dmef2 cDNAs that differ
in their coding sequence and suggested that they arose from
alternative splicing from a single gene (Taylor et al., 1995).
We show here that this is the case, which adds significantly
to the previously published Dmef2 gene structure (Lilly et
l., 1995; Bour et al., 1995). Analysis of Dmef2 genomic
NA shows that the coding region of Dmef2 spans approxi-
ately 5.0 kb and contains nine exons (Fig. 1A). Alternative
plicing results in the inclusion or exclusion of three
lements (Fig. 1A; Taylor et al., 1995). First, after codon
86, toward the middle of the coding sequence, 18 addi-
ional bases can be included due to an alternative 59 splice
onor site. Second, after codon 461, near the 39 end of the
olecule, there is a discrete exon of 75 bases, which can be
ncluded or excluded from the mature transcript. Third, at
he start of exon 10, 21 additional bases can be included due
o an alternative 39 splice acceptor site.
In this paper we analyse four DMEF2 isoforms, I to IV,
hich have the following structures in the regions of
lternative splicing: DMEF2-I contains exons 4b and 10a,
ut not 9; DMEF2-II contains exons 4b and 10b, but not 9;
MEF2-III contains exons 4a and 10b, but not 9; and
MEF2-IV contains 4a, 10b, and 9 (Fig. 1B). None of the
s of reproduction in any form reserved.
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133MEF2 Thresholds for Drosophila Muscle Differentiationalternatively spliced sequences contains a stop codon, and
inclusion of the additional sequences does not alter the
reading frame. Rather the result is distinct DMEF2 protein
isoforms, which differ from one another by the inclusion or
exclusion of additional short peptides in the central and
C-terminal regions. These regions contain transcriptional
activation domains in vertebrate MEF2 proteins (Wong et
l., 1994; Martin et al., 1994; Molkentin et al., 1996).
Ectopic Ectodermal Expression of DMEF2 Results
in Ectopic Expression of the Myosin Gene and
Down Regulation of Epidermal Differentiation
We initiated our analysis of DMEF2 function by using the
GAL4/UAS system (Brand and Perrimon, 1993) to ask what
effect ectopic expression of DMEF2 has in the Drosophila
ectoderm and whether each DMEF2 isoform has the same
effect. We made transgenic lines of flies containing UAS
FIG. 1. The Dmef2 gene is alternatively spliced to produce differe
egion. The alternatively spliced regions are indicated by hatching
ncludes extra bases as a result of an alternative splice donor site or
e have not independently confirmed noncoding exon 1, but this h
and 10 also include noncoding sequence (surrounded by dashed
cale. The evolutionarily conserved MADS box/MEF2 domain (sti
cids of the protein sequence and finishes precisely at the end of e
n this paper. The alternatively spliced regions are again indicated b
r disrupt any protein sequence motif present in the PROSITE data
omain is indicated (stippled box) in each isoform.constructs of each of the four DMEF2 isoforms and, in
addition, studied a previously described line containing
Copyright © 1999 by Academic Press. All rightAS-Dmef2-III (Bour et al., 1995). We used the
aughterless-GAL4 (da-GAL4) line, which expresses GAL4
biquitously, starting at cellularisation and continuing
hrough embryogenesis (Wodarz et al., 1995; Baylies and
Bate, 1996), to drive ectopic expression of each DMEF2
isoform.
Each UAS construct expressed DMEF2 protein in the
ectoderm (not shown). However, as variations in the expres-
sion levels of different UAS constructs can occur due to
different sites of insertion, the protein expressed from each
construct was analysed by Western blot. The levels of
protein produced by each construct are indeed somewhat
different (Fig. 2). In particular, the two lines for Dmef2-III
differ in the level of DMEF2 they produce (Fig. 2B). We have
called these lines Dmef2-III(high) and Dmef2-III(low), ac-
ordingly, and estimate that III(high) expresses approxi-
ately 10-fold the level of III(low). Dmef2-III(low) ex-
presses approximately 2- to 3-fold more protein than the
EF2 isoforms. (A) The genomic organisation of the Dmef2 coding
ns 4 and 10 have two forms “a” and “b” in which the “a” form
ptor site. Exon 9 is an alternatively spliced discrete exon cassette.
en described previously (Lilly et al., 1995; Bour et al., 1995). Exons
. The noncoding transcribed regions and introns are not drawn to
), which includes the DNA binding domain, is the first 86 amino
. (B) The primary structure of the four DMEF2 isoforms described
ching. The inclusion of these additional sequences does not create
(http://www.expasy.ch/sprot/prosite.html). The MADS box/MEF2nt DM
. Exo
acce
as be
line)
ppled
xon 3
y hatlines for Dmef2-I, -II, and -IV (Fig. 2C).
Expression of DMEF2-III(high) in the ectoderm results in
s of reproduction in any form reserved.
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134 Gunthorpe, Beatty, and Taylorthe expression of muscle myosin, a marker of terminal
muscle differentiation, in the majority of epidermal cells
(Fig. 3B). However, unlike during somatic myogenesis,
there is no obvious fusion of these cells (Fig. 3B, inset).
Nevertheless, epidermal differentiation is impaired, be-
cause although a cuticle is secreted, it is extremely thin and
lacks denticles (Fig. 3E). In contrast, early specification of
cells in the ectoderm is not affected, as demonstrated by the
early expression patterns of engrailed (en) (not shown) and
istal-less (Dll) (Fig. 3H), both of which appear wild type
Patel et al., 1989; Cohen, 1990). However, in later embryos
stage 12 onwards), epidermal en expression has a pattern-
ing defect (Fig. 3K). Together these results suggest that
although the cells in the ectoderm are initially specified
correctly, aspects of patterning and terminal differentiation
of the epidermis are impaired.
In order to test the effect of ectopically expressing a lower
level of DMEF2 in the epidermis we repeated these experi-
ments using the Dmef2-III(low) construct. Again a large
number of epidermal cells now ectopically express myosin
(Fig. 3C). Notably, denticles are occasionally found in
epidermal cells that express myosin (Fig. 3C, inset), indi-
cating that DMEF2 can activate muscle genes in cells
expressing a feature of terminally differentiated epidermis.
A thin cuticle is secreted, but it is not as thin as that with
DMEF2-III(high) and also has some denticles, albeit in an
FIG. 2. Western blots showing levels of protein expressed from
the different UAS-Dmef2 constructs. b-Tubulin was assayed as a
oading control. (A) Identification of the DMEF2 band. Lane 1, 50
mef222.21 embryos which express no DMEF2 protein; lane 2, 50
ild-type (OR) embryos. (B and C) A comparison of the levels of
MEF2 expressed from each UAS-Dmef2 isoform construct using
he da-GAL4 driver. In all cases protein was extracted from 20
mbryos. We estimate that the level of DMEF2 expression from
AS-Dmef2III(low) driven by da-GAL4 is approximately 50-fold
hat in wild-type embryos. This corresponds to a level per cell of
pproximately 10-fold that in wild-type embryo muscle, as, from
mbryonic cell number counts (Campos-Ortega and Hartenstein,
997), we estimate that the number of cells in which expression is
riven by the da-GAL4 line is about 5-fold more than the number
n which DMEF2 is expressed in the wild type. (B) Lane 1,
AS-DMEF2-III(low); lane 2, UAS-DMEF2-III(high). (C) Lane 1,
AS-Dmef2-I; lane 2, UAS-Dmef2-II; lane 3, UAS-Dmef2-III(low);
ane 4, UAS-Dmef2-IV.aberrant pattern (Fig. 3F). The expression patterns of both
Dll and en are wild type (Figs. 3I and 3L). Therefore, whilst
Copyright © 1999 by Academic Press. All rightlower levels of DMEF2-III still activate myosin and affect
patterning of the epidermis, there is less of an effect on
epidermal differentiation.
As a first direct test of possible functional differences of
the four DMEF2 isoforms during embryogenesis, we then
asked whether ectopic expression of each of the isoforms
has the same effect. We found that the same phenotype was
observed when DMEF2-I, -II, or -IV was expressed in the
ectoderm (not shown). As with DMEF2-III(low), a large
number of epidermal cells express myosin in each case.
However, en and Dll expression are normal and a cuticle is
ecreted. These cuticles are not as severely affected as those
een with DMEF2-III(low), which correlates with the lower
evel of protein produced from the Dmef2-I, -II, and -IV
ines. They are normal thickness, and more denticle belts
re observed, but again these show patterning defects.
hese results show that each Dmef2 construct produces
unctional DMEF2 protein and that each isoform similarly
ctivates myosin expression and affects epidermal pattern-
ng and differentiation.
Overexpression of DMEF2 within the Mesoderm
Disrupts Differentiation of the Somatic and
Visceral Musculature and the Heart
We continued our investigation of DMEF2 function by
asking what was the effect of overexpression of DMEF2 in
the mesoderm. We used a twist-GAL4 line to drive panme-
sodermal expression from gastrulation until stage 11 (Bay-
lies and Bate, 1996). Thereafter, expression is maintained in
the somatic musculature and the heart, but declines in the
visceral musculature. Overexpression of DMEF2-III(high)
within the mesoderm results in abnormalities in the so-
matic musculature, the heart, and the midgut, as revealed
by an antibody against muscle myosin when compared with
wild-type embryos (Figs. 4A–4C and 4F–4H). In contrast,
both the alary muscles (not shown), which attach the heart
to the epidermis, and the pharyngeal muscle (Fig. 4J) are
unaffected.
There were two effects on the somatic musculature. First,
a number of round, unfused myosin-expressing cells, whose
size, shape, and position suggest they are unfused myo-
blasts, were observed around the muscles (Fig. 4F, inset).
Second, the stereotyped pattern of 30 muscles in each
abdominal hemisegment was disrupted (Fig. 4F). Aberra-
tions in every muscle were seen at least once after scoring
15 hemisegments for defects. These included deletions and
duplications of muscles, as well as muscles found in the
wrong position and muscles with shapes that did not
resemble wild type. However, there did not appear to be a
reproducible pattern to this disruption as the precise defects
varied from segment to segment and from embryo to
embryo. For example, in some hemisegments, the lateral
transverse group of muscles was wild type in appearance
(compare Figs. 4K and 4L). However, in other hemiseg-
ments, aberrations in this group of muscles included
muscles with the wrong shape or attachments (Fig. 4M),
s of reproduction in any form reserved.
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135MEF2 Thresholds for Drosophila Muscle Differentiationduplications (Fig. 4N), and deletions (of one, two, or three
muscles) (Fig. 4O).
The embryonic heart comprises a double row of inner
cardioblasts, surrounded on either side by a row of pericar-
dial cells. In a wild-type embryo, cardioblasts express myo-
sin, whereas pericardial cells do not (Fig. 4C). The overex-
pression of DMEF2-III(high) in the mesoderm resulted in a
disorganisation of the heart. It was somewhat shorter in the
anterior/posterior (A/P) axis, and there were now one or two
additional rows of myosin-expressing cells posteriorly.
There was, however, no increase in the number of cardio-
blasts, rather the total number in these embryos was
actually significantly less than in wild-type embryos (Fig.
4H). An antibody against Zfh-1 (Lai et al., 1991) revealed
hat the pericardial cells, like the cardioblasts, are also
isorganised in the posterior region of the heart (Fig. 4I).
he visceral muscle plays a decisive role in midgut mor-
hogenesis late in embryogenesis when the midgut is
ivided into four compartments by the formation of con-
FIG. 3. Ectopic expression of UAS-Dmef2-III(high) and UAS-Dm
xcept where stated otherwise, and anterior is to the left. In each a
mbryos stained with an antibody against muscle myosin. (A) Wild
yosin expression in the ectoderm. (B) Late-stage embryo ectopical
s expressed in the cells of the ectoderm. Inset: Myosin-expressing c
iew of a stage 16 embryo ectopically expressing DMEF2-III(low).
learly seen ventrally due to the lack of underlying muscle expressi
ow 2 (D–F): Cuticle preparations. (D) Wild-type pattern of dentic
as no denticles. (F) DMEF2-III(low). The cuticle is thin but has dent
1 embryos showing the expression pattern of Dll. (G) Wild-
MEF2-III(low). Dll expression is wild type. Row 4 (J–L): Stage
MEF2-III(high). There is a patterning defect in epidermal En exprtrictions (Bate, 1993). The overexpression of DMEF2-
II(high) in the mesoderm disrupts this normal morphogen-
i
m
Copyright © 1999 by Academic Press. All rightsis and the midgut fails to constrict and has a bloated
ppearance (Fig. 4G).
In contrast to DMEF2-III(high), expression of DMEF2-
II(low) within the mesoderm results in embryos that are
henotypically wild type (not shown). Similarly, no pheno-
ype is produced by the overexpression of DMEF2-I, -II, or
IV. Nevertheless, the results with DMEF2-III(high) demon-
trate that neither too little nor too much DMEF2 activity
s compatible with the proper differentiation of the heart
nd somatic musculature and also the visceral muscle, as
ndicated by the failure of the midgut to constrict. That is,
lthough DMEF2 is required for the proper differentiation of
hese tissues (Bour et al., 1995; Lilly et al., 1995; Ranganay-
kulu et al., 1995), if there is too much DMEF2, then the
ifferentiation of these same three tissues is disrupted. The
isruption of somatic muscle differentiation by overexpres-
ion of DMEF2 in the mesoderm has been reported previ-
usly (M. Lin et al., 1997), but, in contrast to our experi-
ents, no effect on the visceral muscle or heart was found
II(low) in the ectoderm driven by da-GAL4. All views are lateral,
a comparison is made with wild-type (OR) embryos. Row 1 (A–C):
stage 17 embryo showing the somatic muscle pattern. There is no
ressing DMEF2-III(high). These embryos fail to retract and myosin
n the ectoderm do not fuse and remain mononucleated. (C) Ventral
al closure fails and the ectopic epidermal myosin staining is most
set: A denticle growing out of a myosin-expressing epidermal cell.
lts (arrow). (E) DMEF2-III(high). The cuticle is extremely thin and
belts, although their pattern is abnormal (arrow). Row 3 (G–I): Stage
embryo. (H) DMEF2-III(high). Dll expression is wild type. (I)
mbryos showing the expression pattern of En. (J) Wild type. (K)
n (arrow). (L) DMEF2-III(low). En expression is wild type.ef2-I
ssay
-type
ly exp
ells i
Dors
on. In
le be
icle
typen this other study. We attribute this to the use of a different
esodermal GAL4 driver.
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136 Gunthorpe, Beatty, and TaylorDifferent Levels of DMEF2 Rescue Different
Aspects of the Dmef222.21 Mutant Phenotype
We pursued the issue of the importance of the levels of
DMEF2 protein in the differentiation of different types of
muscle in more detail. We asked whether different levels of
DMEF2 could rescue different aspects of the phenotype
associated with a null mutation in Dmef2. Embryos ho-
ozygous for this mutation (Dmef222.21) exhibit a severe
eduction in the number of myosin-expressing cells within
he somatic musculature and fail to form differentiated
uscle fibres. Myosin expression in the visceral muscula-
ure surrounding the midgut is also severely reduced and
he midgut fails to constrict. Myosin expression is absent
rom the alary muscles and the cardial cells of the heart,
FIG. 4. Overexpression of UAS-Dmef2-III(high) within the meso
antibody against muscle myosin unless otherwise stated. Anterio
pattern (lateral view). (B) Visceral musculature and the midgut con
(dorsal view). (D) The outer two rows of pericardial cells (in focus, a
an antibody against Zfh-1. (E) Pharyngeal muscle (arrow) (dorsal vie
Disrupted somatic muscle pattern (lateral view). Inset: There ar
musculature and a bloated midgut (arrow) (ventral view). (H) Heart w
(dorsolateral view). However, along the entire A/P axis the total
significantly less (Mann–Whitney test at 5% level) than in wild-type
of the pericardial cells (arrow) revealed by an antibody against Zfh-1
Row 3 (K–O): The aberrations in the lateral transverse muscles w
embryo in which the LT group of muscles is wild-type in appearan
event. (O) The deletion of all the LT muscles. Only the segment blthough the structure of the heart is formed and appears
ormal, and whilst the pharyngeal muscle is formed, its
f
f
Copyright © 1999 by Academic Press. All rightorphology is severely affected and it does not express
yosin (Bour et al., 1995; our results, not shown).
To rescue the Dmef222.21 phenotype we used 24BGAL4 to
drive expression of UAS-Dmef2-III(low) throughout the
mesoderm of Dmef222.21 mutant embryos from mid-stage 10
Brand and Perrimon, 1993; Michelson, 1994). To assess the
ffects of different levels of DMEF2 in this rescue assay we
ook advantage of the finding that the activity of the GAL4
ystem is temperature sensitive, with greater effects seen at
9°C than at 25 or 18°C (Brand et al., 1994). We estimate
rom Western blot analysis that in our system (UAS-Dmef2-
II(low) driven by 24BGAL4 in a Dmef222.21 background)
here is an approximately 3-fold increase in the amount of
MEF2 protein produced on increasing the temperature
driven by twist-GAL4. Embryos are stage 17 and stained with an
o the left. Row 1 (A–E): Wild-type embryos. (A) Somatic muscle
tions (arrow) (ventral view). (C) Double row of cardioblasts (arrow)
) and the inner two rows of cardioblasts (out of focus) labelled with
ow 2 (F–J): Embryos in which DMEF2-III(high) is overexpressed. (F)
e unfused myoblasts (arrow) around the muscles. (G) Visceral
four rows of myosin-expressing cells in the posterior region (arrow)
ber of cardioblasts (88.6 6 5.3, mean 6 SE, n 5 8) is actually
ryos (100.5 6 1.6, mean 6 SE, n 5 5). (I) A posterior disorganisation
haryngeal muscle has a wild-type appearance (arrow) (dorsal view).
DMEF2-III(high) is overexpressed. (K) Wild-type embryo. (L) An
) LT4 (arrow) is not attached correctly dorsally. (N) A duplication
r muscle (arrow) remains.derm
r is t
stric
rrow
w). R
e som
ith
num
emb
. (J) P
henrom 18 to 25°C and an approximately 2.5-fold increase
rom 25 to 29°C (Fig. 5A). We could therefore assess the
s of reproduction in any form reserved.
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137MEF2 Thresholds for Drosophila Muscle Differentiationeffects of these different levels of DMEF2 on the rescue of
the mutant phenotype by analysing embryos raised at these
temperatures (see Fig. 5B for a summary of results).
At 18°C, DMEF2-III(low) expression fully rescued myosin
FIG. 5. (A) Western blot showing the levels of protein expressed
from UAS-Dmef2-III(low) in Dmef222.21 rescued embryos at 18, 25,
and 29°C using the 24BGAL4 driver. Extracts were from 10 late
stage 12 to stage 14 embryos. b-Tubulin was assayed as a loading
control. Lane 1, 18°C; lane 2, 25°C; lane 3, 29°C. (B) Rescue of the
Dmef222.21 mutant phenotype by UAS-Dmef2-III(low) driven by
24BGAL4. There was some embryo-to-embryo variation in the
extent of rescue produced at each temperature due to the variability
of the GAL4-UAS system. At least 10 stage 17 embryos for each
temperature were therefore scored systematically for rescue. Myo-
sin expression was assessed in the five different muscle types.
Other features assessed were midgut constriction, cell organisation
(heart), presence and shape of cells (pharyngeal), and presence,
attachment, and shape of muscles (somatic). For the somatic
musculature each of the 30 individual muscles per hemisegment in
A2, A3, and A4 was assessed in each embryo. Bar chart: Summary
of the rescue of the mutant phenotype by DMEF2-III(low) at 18, 25,
and 29°C, showing the percentage of embryos in which various
features of the phenotype were rescued to wild type. Table:
Summary of the somatic muscle rescue by DMEF2-III(low) at 18,
25, and 29°C. Individual muscles were scored as rescued if com-
pletely wild type in appearance in more than 50% of hemisegments
assessed. The nomenclature of Bate (1993) is used.expression in the visceral muscle in 100% of embryos and
rescued midgut constrictions in 90% of embryos (Fig. 6A). w
Copyright © 1999 by Academic Press. All rightyosin expression was rescued in all alary muscles in 70%
f these embryos (Fig. 6C), while in the remainder myosin
xpression in the posterior alary muscles was rescued more
requently than in the anterior. In 50% of these embryos the
haryngeal muscles were wild type, while in the other 50%
ome cells did not express myosin and most were abnor-
ally shaped (Fig. 6B). The rescue of the somatic muscles
as assessed by scoring whether each of the 30 distinct
uscles per hemisegment was rescued in more than 50% of
he hemisegments examined. Only a subset of muscles was
escued (see Table in Fig. 5B), but these included some
orsal muscles (DT1), some lateral (LL1, SBM), and some
entral (VT1, VA1/2); that is, there is no obvious dorsal/
entral (D/V) difference. In addition, there were unfused
yoblasts in the majority of hemisegments (not shown). A
ange of phenotypes was seen in the heart. In 20% of
mbryos myosin expression was rescued in all cardioblasts.
n the other cases, myosin expression was rescued only in a
ubset of cardioblasts, with pairs at the border of each
egment prominent and often more expression posteriorly.
n some embryos, these pairs were the only cardioblasts
xpressing myosin all along the heart (Fig. 6C).
At 25°C, DMEF2-III(low) expression now fully rescued
yosin expression in the alary muscles (Fig. 6J), as well as
he midgut constrictions and myosin expression in the
isceral muscle in all embryos (Fig. 6H). In 30% of embryos
he shape of some of the pharyngeal muscle cells was not
ild type, although all cells now expressed myosin (Fig. 6E).
n the other embryos, the pharyngeal muscle was fully
escued (Fig. 6I). The variety of phenotypes in the heart was
imilar to that seen at 18°C (Figs. 6F and 6J). The somatic
usculature is almost rescued to wild type (Fig. 6K),
lthough occasionally one or two muscles in a hemiseg-
ent are absent or have the wrong shape (Fig. 6G).
At 29°C, DMEF2-III(low) expression again completely
escued myosin expression both in the visceral muscle,
lthough there were no midgut constrictions (Fig. 6L), and
n the alary muscles (not shown). The pharyngeal muscles
ere now also completely rescued (Fig. 6M). In contrast,
yosin expression was completely rescued in the cardio-
lasts in only about 35% of embryos, and in half of these
he heart was disorganised posteriorly (Fig. 6N). In the other
mbryos, there was myosin expression in varying numbers
f cardioblasts, but in all cases the pairs of cardioblasts at
he border of each segment were again prominent. The
omatic musculature was fully rescued in these embryos:
he pattern of myosin-expressing fibres was essentially wild
ype, although there were some unfused myoblasts in the
ajority of hemisegments (Fig. 6O). Three features of this
henotype, no midgut constrictions, the disorganisation of
he posterior end of the heart, and the appearance of
nfused myoblasts in the somatic musculature, appear to
e due to too much DMEF2 function as they resemble the
henotype seen when DMEF2 was overexpressed in the
esoderm.
In these rescue experiments there is a phenotypic series
hich shows that there is a DMEF2 activity range compat-
s of reproduction in any form reserved.
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138 Gunthorpe, Beatty, and Taylorible with the proper differentiation of the different muscle-
types. Rescue is incomplete at low levels, there is rescue to
wild type at intermediate levels, and differentiation is
disrupted at higher levels. We also note that aspects of the
phenotype after overexpression of DMEF2 in the meso-
derm, i.e., unfused myoblasts and no midgut constrictions,
resemble the phenotype resulting from reduced Dmef2
function. A formal framework in which to consider this
type of result has been described (Bray and Lay, 1997). In a
multiprotein complex, for example one that regulates tran-
scription, too little or too much of some components will
affect concentration-dependent interactions within the
complex and disrupt it and hence its function. Here, the
FIG. 6. A comparison of different aspects of the Dmef222.21 mutan
5, and 29°C. All embryos are stage 17 and stained with an antibo
idgut constrictions and myosin expression in the midgut viscera
haryngeal muscle (dorsal views). Column 3, rescue of myosin e
olumn 4, rescue of the somatic musculature (lateral views). Row
arrow) and myosin expression in the visceral muscle. (B) Incomp
arrowhead) and many are misshapen. (C) Myosin expression in so
uscle DT1 (arrowhead) has incorrect attachments ventrally and i
t 25°C (we did not observe incomplete rescue of the midgut). (E)
xpression is rescued in posterior cardioblasts, but pairs are still pro
xamples of complete rescue at 25°C. (H) Midgut constrictions and
J) Myosin expression in all cardioblasts and alary muscles (some o
as a wild-type appearance. Row 4 (L–O): Examples of rescue at 29
onstrictions are incomplete (arrow). (M) Pharyngeal muscle appea
O) Unfused myoblasts in the somatic musculature (arrowhead).interaction between DMEF2 and putative cofactors might
be affected.
m
m
Copyright © 1999 by Academic Press. All rightA striking finding in our rescue experiments is that
ifferent DMEF2 requirements are revealed in three distinct
spects of muscle differentiation. First, different properties
ithin a cell have different requirements for DMEF2. Thus,
t lower levels (18°C), some somatic muscles are incorrectly
ttached to the epidermis (Fig. 6D), whereas at higher levels
25°C) some muscles are attached in the correct position,
ut have an abnormal shape (Fig. 6G). This suggests that
ome muscle properties (shape) may require higher levels of
MEF2 than others (attachment). In each case these
uscles expressed myosin, suggesting that myosin gene
xpression requires lower levels of DMEF2 than those
equired for attachment. Similarly, in the pharyngeal
notype rescued by UAS-Dmef2-III(low) driven by 24BGAL4 at 18,
ainst muscle myosin. Anterior is to the left. Column 1, rescue of
scle (lateral views). Column 2, rescue of myosin expression in the
ssion in the alary muscles and heart cardioblasts (dorsal views).
–D): Rescue at 18°C. (A) Complete rescue of midgut constrictions
rescue of pharyngeal muscle. Some cells do not express myosin
lary muscles (arrowhead) and in pairs of cardioblasts (arrow). (D)
aller than wild type. Row 2 (E–G): Examples of incomplete rescue
e pharyngeal muscle cells are misshapen (arrowhead). (F) Myosin
nt (arrow). (G) Muscle DT1 is misshapen (arrowhead). Row 3 (H–K):
in expression in the visceral muscle (arrow). (I) Pharyngeal muscle.
focus). (K) The somatic muscle pattern. Muscle DT1 (arrowhead)
complete rescue is due to too much DMEF2 function. (L) Midgut
ld type. (N) Disorganisation of the cardioblasts posteriorly (arrow).t phe
dy ag
l mu
xpre
1 (A
lete
me a
s sm
Som
mine
myos
ut of
°C. Inuscle at 25°C all the cells were present and expressing
yosin, but some had abnormal morphology. This again
s of reproduction in any form reserved.
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139MEF2 Thresholds for Drosophila Muscle Differentiationindicates that higher levels of DMEF2 are required for
correct cell morphology than for myosin expression.
Second, different cells within a muscle type have differ-
ent requirements for DMEF2. This is found in the somatic,
pharyngeal, and alary muscle and in the heart (Fig. 6). Some
somatic muscles, that is, those seen consistently at 18°C,
are rescued at lower levels of DMEF2 than others. Similarly,
at 18°C some cells in the pharyngeal muscle did not express
myosin, and myosin expression in posterior alary muscles
was rescued before that in anterior alary muscles. Finally,
in the heart, pairs of cardioblasts along the entire A/P axis
were rescued most readily, although again there appears to
be a posterior preference with posterior pairs being rescued
more readily than anterior pairs.
Third, different muscle types have different requirements
for DMEF2. Relatively low levels of DMEF2 (18°C) rescue
myosin expression in the visceral muscle together with, in
almost all embryos, the midgut constrictions. Higher levels
(25°C) are required for complete rescue of the alary muscles,
whilst the pharyngeal muscle and somatic musculature are
only fully rescued with the higher levels produced at 29°C.
Complete rescue of myosin expression in the heart is only
achieved in about 35% of embryos at 29°C, indicating that
this tissue is the most difficult to rescue.
Rescue of Different Aspects of the Dmef222.21
Phenotype by Each of the Four DMEF2 Isoforms
As a rigorous test of potential functional diversity be-
tween DMEF2 isoforms we examined whether there was a
difference in the ability of UAS-Dmef2 of each isoform
driven by 24BGAL4 to rescue the defects associated with
Dmef222.21. We again assessed the phenotype in detail to
etermine whether there were differences in any aspect of
he different tissues assayed. At 18°C, the rescue of the
mef222.21 phenotype by each isoform was similar (Fig. 7A),
although again DMEF2-III(low) was somewhat more active
than isoforms I, II, and IV. Two additional points can be
made. First, each aspect of the mutant phenotype showed
the same characteristics of partial rescue with each isoform,
indicating that each isoform acts to rescue the mutant
phenotype in the same way. Second, the effect of less
DMEF2 activity than DMEF2-III(low) at 18°C is revealed by
the other isoforms, as isoforms I, II, and IV are expressed at
a lower level than III(low) (Fig. 7B). In the somatic muscu-
lature, muscle LL1 is rescued only by DMEF2-III(low),
indicating that this muscle requires a higher level of
DMEF2 to differentiate than muscles that are rescued by all
isoforms, e.g., VT1 and VA1/2. Also, with isoforms I, II, and
IV, whilst all embryos showed complete rescue of myosin
expression in the visceral muscle, not all had midgut
constrictions. This confirms the indication from III(low)
that myosin expression does indeed require lower levels of
DMEF2 than the midgut constrictions.
Each isoform behaved similarly and gave partial rescue at
18°C. We then asked whether each isoform could rescue
essentially all aspects of the phenotype at 29°C (Fig. 7A).
t
t
Copyright © 1999 by Academic Press. All rightoth the pharyngeal muscle and the alary muscles were
ully rescued in all cases. The somatic musculature was
ssentially rescued by all four isoforms, although occa-
ional muscles in some hemisegments were missing. Un-
used myoblasts seen in embryos rescued by DMEF2-
II(low) at 29°C were not observed in embryos rescued by
soforms I, II, and IV. This is likely to be a consequence of
he higher level of expression of protein driven from the
AS-Dmef2-III(low) line. Myosin expression in the visceral
uscle was rescued in all cases, but there were no midgut
onstrictions, which is, as we have shown, one conse-
uence of too much DMEF2 activity. Only DMEF2-III(low)
as capable of rescuing myosin expression in all the car-
ioblasts. This, again, is likely to be due to the higher levels
f protein driven from this line rather than an isoform-
pecific effect, as with isoforms I, II, and IV we do see rescue
f myosin expression in some cells of the heart. Embryos
escued by these other isoforms had phenotypes similar to
hose described for isoform III at 25 and 18°C, with pairs of
yosin-expressing cardioblasts prominent. We conclude
rom these results that each DMEF2 isoform is essentially
apable of rescuing each aspect of the Dmef222.21 phenotype
ssayed in these experiments.
DISCUSSION
We have explored the function of DMEF2 in diverse
events of muscle differentiation. Whilst it was known that
many features of the differentiation of the different muscle
types are Dmef2-dependent and that others are Dmef2-
independent (see Introduction), the results in this paper
highlight an additional significant facet of DMEF2 function.
There is not simply an all-or-none requirement for DMEF2,
but rather the levels of this transcription factor have a
profound effect. There are two aspects to this. First, there is
a DMEF2 activity range compatible with proper muscle
differentiation, and, second, there are different thresholds of
DMEF2 activity for different events in muscle differentia-
tion.
DMEF2 Levels Affect Different Aspects of Muscle
Differentiation
The existence of a DMEF2 activity range compatible with
the proper differentiation of the somatic and visceral mus-
culature and the heart is demonstrated by the phenotypic
series obtained in our experiments in which the Dmef2
utant phenotype is rescued by different levels of DMEF2.
t low levels rescue is incomplete, at intermediate levels
here is rescue to wild type, and at higher levels differen-
iation is disrupted. Disruption at higher levels is also
hown by our experiments in which DMEF2 is overex-
ressed in the mesoderm.
We investigated the issue of different thresholds of
MEF2 activity for different aspects of muscle differentia-ion directly by exploiting the temperature sensitivity of
he GAL4 system to add back different levels of DMEF2 to
s of reproduction in any form reserved.
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140 Gunthorpe, Beatty, and TaylorFIG. 7. (A) A comparison of the rescue of each aspect of the Dmef222.21 mutant phenotype by each of the DMEF2 isoforms at 18 and 29°C.
he bar charts show the percentage of embryos that were rescued to wild type for myosin expression in the visceral muscle, midgut
onstrictions, pharyngeal and alary muscles and myosin expression in the cardioblasts. The tables show rescue of the somatic muscles.
lthough isoforms I, II, and IV do not rescue myosin expression in all cardioblasts (i.e., to wild type), each rescues it in some. Isoform IV
s the least efficient, which correlates with its lower level of expression. Indeed, considering all aspects of the phenotype there is a
orrelation between the level of expression of each isoform and the degree to which it rescues the Dmef222.21 mutant phenotype. (B) Western
blot showing the levels of DMEF2 protein expressed from the UAS lines of each isoform using the 24BGAL4 driver in Dmef222.21 rescued
mbryos. b-Tubulin was assayed as a loading control. We estimate that isoform III(low) is expressed at a level approximately 1.5-fold higher
han I and II and approximately 3-fold higher than IV.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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141MEF2 Thresholds for Drosophila Muscle DifferentiationDmef2 mutant embryos. We then assayed the presence or
absence of each somatic muscle and its characteristics
together with those of the other distinct muscle types that
DMEF2 affects, that is, the visceral, pharyngeal, and alary
muscle and the heart. Different DMEF2 requirements were
revealed in three distinct aspects of muscle differentiation:
different properties within a cell, different cells within a
muscle type, and different muscle types.
The requirement of different properties within a cell for
different levels of DMEF2 was found in the somatic, vis-
ceral, and pharyngeal muscle. It is clearly illustrated by
myosin expression, muscle attachment, and correct muscle
shape in the somatic muscles. An interpretation of these
results is that DMEF2 has multiple gene targets and some
are activated at lower DMEF2 levels than others. Similarly,
in the visceral muscle, myosin expression requires a lower
level of DMEF2 than the properties necessary for constric-
tion of the midgut. This too could be a consequence of
multiple gene targets where PS2a might be a DMEF2 target
n the visceral muscle required for midgut constrictions
Ranganayakulu et al., 1995).
The requirement of different cells within a muscle type
or different levels of DMEF2 was found in the heart and in
he somatic, pharyngeal, and alary muscles. Again it is
learly illustrated by the somatic muscle. Each muscle is a
ultinucleate cell and some, e.g., VA1/2, require lower
evels of DMEF2 than others, e.g., LL1, which in turn
equire lower levels than others, e.g., VA3. Similarly, in the
ardioblasts, the expression of myosin in response to
MEF2 is not uniform. Both within a segment and along
he A/P axis, different cells require different thresholds of
MEF2 activity to activate myosin expression. This indi-
ates that genetically the cardioblasts are a nonuniform
opulation of cells. This genetic nonuniformity is also
ndicated by genes and enhancers expressed in subsets of
he cardioblast population (Hartenstein and Jan, 1992; Jagla
t al., 1997; Gajewski et al., 1997, 1998; Nguyen and Xu,
998). Finally, we found that different muscle types require
ifferent levels of DMEF2. For example, the visceral muscle
an fully differentiate at lower levels of DMEF2 than the
haryngeal and somatic muscle.
An indication that levels of DMEF2 might be important
n the specific case of somatic muscle development has
ome previously from observing the presence or absence of
ndividual muscles in three hypomorphic Dmef2 alleles
Ranganayakulu et al., 1995; see Introduction). We have
nalysed these alleles in the same detailed manner as in our
escue experiments for each of the five muscle types and
ave again found differential effects in these alleles on
roperties within a cell, on cells within a muscle type, and
n different muscle-types (D.G. and M.V.T., unpublished
ata). The similarity of the results from this analysis to
hose from our experimental design of rescue of the Dmef2
ull mutant phenotype strongly suggests two things: first,
hat the results from our experiments do indeed reflect the
unctional consequences of a difference in DMEF2 levels,
o
Copyright © 1999 by Academic Press. All rightnd second, that these Dmef2 alleles do form an allelic
eries considering many aspects of the phenotype.
In our analysis of these hypomorphic Dmef2 alleles, we
gain found that different properties of a cell have different
equirements for Dmef2. In the somatic muscle in the
trongest allele, there are myosin-expressing but incorrectly
ttached muscles, and in the other two alleles there are
yosin-expressing and attached muscles that are mis-
hapen (e.g., DT1). Another example is the pharyngeal
uscle, in which in both the intermediate and the weakest
lleles some cells again express myosin but are misshapen.
xamples of the effect on different cells within a muscle-
ype are the alary and somatic muscles. In the strongest
llele myosin-expressing alary muscles are found posteri-
rly but not anteriorly. In the intermediate and weakest
lleles some individual somatic muscles are present when
thers are not. Our analysis shows that the muscles present
n these alleles can almost be superimposed on those
resent in our rescue experiments. For example, the
uscles missing in the intermediate allele are a subset of
hose missing in the embryos rescued at 18°C with DMEF2-
II. Muscles can be restored by the provision of increased
evels of DMEF2 function, either by the weakest Dmef2
llele or by increasing the rescue temperature to 25°C.
Finally, different muscle types again have different
mef2 requirements. In the strongest allele, none of the
uscle types is wild type, whereas in the intermediate
llele both the visceral and the alary muscles are wild type,
nd in the weakest allele the pharyngeal and somatic
uscles are now almost wild type as well. As in our rescue
xperiments, it is the heart that requires most Dmef2
unction as even in the weakest allele myosin expression in
ll cardioblasts was observed in only 20% of embryos.
aken together, the results from the rescue experiments
nd from these hypomorphic alleles demonstrate that levels
f DMEF2 activity can affect different aspects of the differ-
ntiation of the five muscle types we have analysed. One
an now ask whether levels of DMEF2 have a role in normal
uscle development.
Is There a Role for Different DMEF2 Levels in
Development?
Three pieces of evidence that have been used to indicate
a role for different levels of a protein during development
are the following: the wild-type expression pattern (and the
enhancers that control it), the phenotype of different alleles,
and the effect of manipulating levels of expression. To-
gether this information establishes whether the protein is
differentially expressed and whether there is a developmen-
tal consequence to changes in the level of a protein. There
is supportive evidence for both in the case of DMEF2.
There is evidence that different cells and different tissues
express different levels of DMEF2 and regulate Dmef2
xpression by independent mechanisms. First, the pattern
f Dmef2 expression in the embryo is complex and some
cells express higher levels than their neighbours (Lilly et al.,
s of reproduction in any form reserved.
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142 Gunthorpe, Beatty, and Taylor1994, 1995; Nguyen et al., 1994, Taylor et al., 1995; Bour et
l., 1995). Second, analysis of the Dmef2 gene regulatory
equences reveals many distinct enhancer elements. For
oth the somatic muscle and the heart separate enhancers
hat drive expression from different stages of embryogenesis
ave been found (Nguyen and Xu, 1998). One possible
onsequence of this is that levels of DMEF2 increase in
hese tissues during embryogenesis, which is consistent
ith our hypothesis that different genes are sequentially
ctivated in individual cells as development proceeds.
here are also enhancers active in only a subset of heart
ells or somatic muscle cells (Schulz et al., 1996; Gajewski
t al., 1997, 1998; Nguyen and Xu, 1998), and finally, there
re distinct enhancer elements for the heart and for so-
atic, visceral, and pharyngeal muscle (Gajewski et al.,
997; Cripps et al., 1998; Nguyen and Xu, 1998). These
ndings indicate that expression in different cells of a
uscle type and in different muscle types is independently
egulated. This is the arrangement expected if different cells
ithin a muscle type and different muscle types both
xpress different levels of DMEF2.
As discussed above, we have shown that there are conse-
uences for muscle differentiation from changes in the level
f DMEF2 activity. We have manipulated the levels of
MEF2 activity by adding back different levels of DMEF2
o Dmef2 mutant embryos and overexpressing DMEF2 in a
ild-type background. We have also assessed the pheno-
ypes of three Dmef2 hypomorphic alleles, which can now
e interpreted as reducing DMEF2 activity, rather than
evealing allele-specific effects, as discussed above. In both
hese alleles and in our experiments in which DMEF2 levels
re manipulated we find a consistent series of effects on
ifferentiation in the five muscle types we have assessed.
his correlation between DMEF2 levels and muscle pheno-
ype, together with the Dmef2 gene expression data, sug-
ests that DMEF2 levels are indeed important in these
ifferent aspects of muscle differentiation.
One can speculate on the possible roles in normal devel-
pment for the distinct DMEF2 thresholds we have ob-
erved. First, there are different thresholds for different
roperties within a cell. As suggested above, these thresh-
lds may be due to the sequential activation by DMEF2 of
ifferent genes in individual cells as development proceeds.
ifferent genes could have different thresholds for tran-
criptional activation, although there are very few charac-
erised examples of this concept. It is perhaps most clearly
llustrated by another Drosophila transcription factor, Dor-
al, which functions early in development in the establish-
ent of the embryonic D/V axis. There is a concentration-
ependent activation of different target genes by Dorsal
ith at least five different thresholds for gene activation
Huang et al., 1997). The identification and analysis of
MEF2 target genes is essential to achieve a full molecular
xplanation of our observation of different thresholds for
ifferent properties within a cell. However, to date, only
wo direct DMEF2 targets have been described, TmI and
b3tubulin (M. Lin et al., 1996; Damm et al., 1998), and the
t
d
Copyright © 1999 by Academic Press. All rightdentification of additional direct targets is required. What-
ver the molecular mechanism, one can ask what might be
he role for these different thresholds. One possibility is
hat during normal differentiation there is a sequential
ctivation of different genes as DMEF2 activity increases.
he proper differentiation of the cell might depend on the
rder of gene activation, that is, it might be important that
ne gene is activated before another.
Our work also suggests that different cells within a
uscle type have different threshold requirements for
MEF2. For the somatic muscle, this could be part of a
echanism by which some muscles might embark on
articular stages of differentiation and/or acquire specific
eatures before others (see, for example, Bate, 1993). This
ight be important for the proper organisation of the entire
uscle pattern. Our studies in which the wild-type DMEF2
xpression pattern is modified by additional expression in
he mesoderm, which produces unfused myoblasts and a
ide range of defects in the somatic muscle pattern, are
onsistent with such a view. Similarly, in the heart, the
ifferential effect of DMEF2 might reflect an order in which
he cells must reach a particular point of differentiation.
his is again consistent with additional mesodermal ex-
ression of DMEF2 resulting in a disorganised heart. This
onuniformity might also reflect differences between cells,
erhaps analogous to the distinct populations of cells that
rise at different positions along the A/P axis of the devel-
ping heart tube in vertebrates (Fishman and Olson, 1997).
Finally, our work suggests that some muscle-types have
ower threshold requirements for DMEF2 than others. The
ignificance of this remains to be determined. However, we
ote that visceral muscle has a lower threshold than so-
atic muscle, which has a lower threshold than the heart,
nd that in normal development the visceral muscle ex-
resses muscle myosin before the somatic muscle, which in
urn expresses it before the heart.
Function of DMEF2 Isoforms
All mef2 genes that have been analysed are alternatively
spliced, but our work is the first in vivo assessment in any
pecies of the functions of the different isoforms from a
ingle mef2 gene. Having first defined the functions of
MEF2 in diverse events of the differentiation of different
uscle types, we then evaluated whether the different
MEF2 isoforms differed in any of these functions. It has
een speculated that the small alternatively spliced regions
f the vertebrate MEF2 proteins might interact with differ-
nt proteins and hence that the different isoforms might
ave different functions (Breitbart et al., 1993; McDermott
t al., 1993). However, we found that each DMEF2 isoform
ehaved equivalently in each experiment. In particular, in a
tringent test for embryonic function, that is, rescue of the
utant phenotype, we showed that each of the four iso-
orms tested can function in the same way in the differen-
iation of the five different muscle types from the meso-
erm. It remains possible, however, that there are
s of reproduction in any form reserved.
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143MEF2 Thresholds for Drosophila Muscle Differentiationfunctional differences between the isoforms that are only
manifest in the larva or adult. We also found that the
different isoforms functioned similarly in a dominant man-
ner after ectopic expression in the ectoderm where they all
activated myosin expression and affected epidermal pat-
terning and differentiation.
The Consequences of Ectopic DMEF2 Expression
In our ectopic expression experiments at relatively low
levels of DMEF2, elements of both the epidermal and the
muscle differentiation programmes are expressed in indi-
vidual cells. However, when the level of DMEF2 is in-
creased then the epidermal differentiation programme is
suppressed. We estimate that the level of DMEF2 expres-
sion that causes a thin cuticle, results in severe effects on
denticles, and induces ectopic myosin expression is ap-
proximately 10-fold that in the muscle of wild-type em-
bryos (see Fig. 4). The ectopic activation of myosin expres-
sion in cells manifesting a feature of another terminally
differentiated cell type, the denticle of the epidermal cell,
can be compared with the activation of muscle genes by
MyoD in cultured cells also showing aspects of another
phenotype (Weintraub et al., 1989). The activation of a
gene, myosin, but not other features of somatic myogenesis,
by DMEF2 can also be compared with the effect of frog
MEF2, which ectopically activates a cardiac myosin gene,
but not the cardiomyogenic programme (Chambers et al.,
1994). Similarly, in cell culture two groups have found that
MEF2 cannot convert fibroblasts into myoblasts, although
there is an earlier report that it can (reviewed in Yun and
Wold, 1996).
Another group has reported the results of ectopic expres-
sion of DMEF2 in the ectoderm (M. Lin et al., 1997). They
lso found ectopic activation of muscle genes, but in
arked contrast to our results there was no effect on
pidermal differentiation, nor did they report denticles in
ells expressing muscle genes. In both ectopic expression
nd overexpression experiments we saw qualitatively more
ramatic results than in this other report, which can be
ttributed to our using different GAL4 drivers. Our effect
ith ectopic expression of DMEF2 in the ectoderm can also
e compared with that of the HLH protein Twist (Twi)
sing the same GAL4 driver (Baylies and Bate, 1996). Both
MEF2 and Twi suppress epidermal differentiation, but in
ontrast to DMEF2, Twi also suppressed Dll expression and
nduced di- and trinucleated myosin-expressing cells in the
ctoderm characteristic of the initial steps of somatic
yogenesis. This difference might simply be a quantitative
ffect, that is, more Twi than DMEF2 activity, or it may
eflect a qualitative difference, in which Twi can activate
uscle genes that DMEF2 cannot.
Concluding RemarksFuture developments in understanding muscle differen-
tiation in both Drosophila and vertebrates will require an
Copyright © 1999 by Academic Press. All rightnalysis of such MEF2-dependent and -independent events.
he novel results described here, which include the finding
f distinct DMEF2-dependent events in different muscle
ypes with different threshold requirements for DMEF2,
ndicate the importance of the levels of this transcription
actor to the regulation of many features of muscle differ-
ntiation. This issue will need to be incorporated into the
iew of how MEF2, which is a major player in muscle
ifferentiation, functions to regulate diverse events in dif-
erent muscle types. In animal development, it is in the
ontext of the morphogens and patterning genes that estab-
ish the basic body plan that the importance of levels of
rotein activity has generally been considered (see, for
xample, Gurdon et al., 1998). Our findings provide an
xample of how different levels of protein activity might
lso be important for transcription factors that act later in
he process of cell differentiation. The general conservation
f molecular mechanisms in muscle differentiation be-
ween Drosophila and vertebrates suggests that specific
ndings about Dmef2 will be significant for mef2 genes in
ther species in understanding their crucial role in muscle
ifferentiation.
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